XBiotech Inc. — Director's Dealing 2018

Aug 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2018-07-30

Reporting Person: MCKENZIE W THORPE (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-30	Common Stock	S	5344	$4.4054	Disposed	94656	Indirect
2018-07-31	Common Stock	S	6531	$4.4894	Disposed	88125	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3898600	Direct
Common Stock	11500	Indirect
Common Stock	100000	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.45, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.41to $4.54, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.